← Back to headlines
Insulet Downgraded by Oppenheimer Due to Growing Risks
Medical device company Insulet received a downgrade from Oppenheimer, citing increasing risks associated with the company's outlook.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.